Rechargeable neurostimulator joins the Medtronic Percept™ family – the first and only deep brain stimulation system with sensing, directionality, and advanced programming.DUBLIN, Jan. 8, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S.

可充电神经刺激器加入美敦力感知™家庭-第一个也是唯一一个具有感知、方向性和高级编程功能的大脑深部刺激系统。都柏林，2024年1月8日/PRNewswire/--医疗保健技术的全球领导者美敦力公司（纽约证券交易所：MDT）今天宣布。

Food and Drug Administration (FDA) approval of its Percept™ RC Deep Brain Stimulation (DBS) system. The rechargeable neurostimulator is the latest innovation in the Medtronic Percept™ family, which includes the Percept™ PC neurostimulator, BrainSense™ technology†, and SenSight™ directional leads. The Percept™ family is the only sensing-enabled DBS system on the market, allowing the physician to personalize treatment for patients with movement disorders such as Parkinson's disease, essential tremor, and dystonia* as well as epilepsy.

食品和药物管理局（FDA）批准其感知™ RC深部脑刺激（DBS）系统。可充电神经刺激器是美敦力Percept的最新创新™ 家庭，其中包括感知™ PC神经刺激器，BrainSense™ 技术†和SenSight™ 定向引线。感知™ family是市场上唯一一个能够感知的DBS系统，允许医生对帕金森氏病、原发性震颤、肌张力障碍*和癫痫等运动障碍患者进行个性化治疗。

Over 11 million people in the U.S. are living with movement disorders1-2 and approximately 3.4 million with epilepsy3..

美国有1100多万人患有运动障碍1-2，约340万人患有癫痫3。。

Continue Reading

继续阅读

Medtronic Percept™ RC

美敦力感知™ 钢筋混凝土

'Our DBS therapy with exclusive BrainSense™ technology can help control debilitating tremors for people living with Parkinson's, providing patients with the ability to physically engage in everyday moments – something many of us unintentionally take for granted,' said Amaza Reitmeier, vice president and general manager, Brain Modulation within the Neuromodulation business, which is part of the Neuroscience Portfolio at Medtronic.

“我们的独家BrainSense DBS治疗™ 美敦力（Medtronic）神经调节业务（Neuromulation business）的大脑调节副总裁兼总经理阿玛莎·雷特梅尔（AmazaReitmeier）说，技术可以帮助控制帕金森氏症患者的衰弱性震颤，为患者提供参与日常生活的能力，这是我们许多人无意中认为理所当然的事情。

'We are transforming brain modulation through sensing-enabled DBS and will continue to drive therapy innovation with the goal of many more peoples' lives improved with Medtronic DBS therapy.'.

“我们正在通过感知DBS改变大脑调节，并将继续推动治疗创新，目标是通过美敦力DBS治疗改善更多人的生活。”。

DBS uses a surgically implanted medical device, similar to a cardiac pacemaker. Medtronic Percept™ neurostimulators transmit electrical signals via slender wires to specific brain targets affected by debilitating neurological disorders like Parkinson's disease.

DBS使用手术植入的医疗设备，类似于心脏起搏器。美敦力感知™ 神经刺激器通过细长的电线将电信号传递给特定的大脑目标，这些目标受到帕金森氏病等衰弱性神经疾病的影响。

Percept™ RC is the smallest and thinnest dual channel‡ neurostimulator available for DBS. It is equipped with BrainSense™ technology that captures and records brain signals to provide insights that enable a healthcare provider to adapt and personalize therapy to a patient's evolving needs. Unlike other rechargeable devices, the Percept™ RC battery offers at least 15 years of service life with consistent and fast recharge performance.

感知™ RC是DBS可用的最小和最薄的双通道神经刺激器。它配备了BrainSense™ 捕获和记录大脑信号的技术，以提供见解，使医疗保健提供者能够根据患者不断变化的需求调整和个性化治疗。与其他可充电设备不同，Percept™ RC电池具有至少15年的使用寿命，并具有一致且快速的充电性能。

Medtronic patented battery technology has less battery fade than other rechargeable devices for a more reliable, long-lasting battery.§  Patients can experience rapid recharging from 10% to 90% full charge in less than an hour.Ω  'While more data are needed, the sensing capability of this unique deep brain stimulation system allows me the potential to tune stimulation delivery to brain activity, which may be a way to personalize this therapy for Parkinson's disease in the future,' said Casey H.

美敦力专利电池技术比其他可充电设备的电池衰减更少，电池更可靠，寿命更长。§患者可以在不到一小时的时间内快速充电，从10%到90%完全充电。Ω'虽然需要更多数据，但这种独特的大脑深部刺激系统的感知能力使我有可能调整刺激传递到大脑活动，这可能是未来个性化帕金森氏病治疗的一种方法，'CaseyH。

Halpern, M.D., Neurosurgeon and deep brain stimulation expert.Nearly 70 percent of all DBS-eligible patients are estimated to require an MRI as part of their essential care4.  Medtronic was the first in the United States to offer full-body MR Conditional DBS systems for patients to have safe scans anywhere on the body under specific conditions††. Percept™ offers greater freedom and scan access for patients with 3T scans and best-in-class 1.5T MRI scan labeling5-7.

Halpern，医学博士，神经外科医生和深部脑刺激专家。据估计，在所有符合DBS条件的患者中，近70%的患者需要进行MRI检查，作为其基本护理的一部分4。美敦力是美国第一家为患者提供全身MR条件性DBS系统的公司，以便在特定条件下对身体任何地方进行安全扫描††。感知™ 为3T扫描和一流的1.5T MRI扫描标签5-7的患者提供更大的自由度和扫描访问。

Medtronic has the only DBS system that allows patients to have stimulation on in bipolar mode during an MRI5-7.†† In addition, the Percept™ neurostimulators are engineered to allow for future software updates designed for the Percept™ platform without a neurostimulator device exchange.†† Under specific conditions.

美敦力拥有唯一的DBS系统，允许患者在MRI5-7期间以双极模式进行刺激。†††此外，Percept™ 神经刺激器的设计是为了允许未来为Percept设计的软件更新™ 没有神经刺激装置交换的平台。††在特定条件下。

Refer to product labeling for full list of conditions: https://manuals.medtro.

有关条件的完整列表，请参阅产品标签：https://manuals.medtro.

Contacts:

联系人：

Naomi Rodiles

Naomi Rodiles

Ryan Weispfenning

Ryan Weispfenning

Public Relations

公共关系

Investor Relations

投资者关系

+1-612-427-5521

+1-612-427-5521

+1-763-505-4626

+1-763-505-4626

SOURCE Medtronic plc

来源美敦力plc